All lobbying filings

ZIMMER BIOMET, INC.

Lobbying for ZIMMER BIOMET, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $190,000.00 expenses · posted Jul 15, 2025

Official filing document

Bills named in this filing 1

HR 1539
Medical Device Electronic Labeling Act

Lobbying activity 6

Medicare/Medicaid

Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment

Trade (domestic/foreign)

Trade Issues/Policy

Taxation/Internal Revenue Code

Tax Issues

Environment/Superfund

EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS

Science/Technology

Medical Device Electronic Labeling Act (H.R. 1539)

Health Issues

Assorted issues related to the FDA

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.